ReviewJournal of hematology & oncology2023

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.

Charles M Rudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.